Thyroidectomy Shows Noninferiority Without Radioiodine in Thyroid Cancer
A greater proportion of excellent responses were reported without radioiodine than with radioiodine when treating patients with low-risk thyroid cancer.
Expanding and Advancing the Future of Renal Cell Carcinoma Treatment
Eric Jonasch, MD, believes that the Kidney Cancer Research Consortium may broaden their reach to provide care to many different groups of patients.
Genomic Features May Define Patient Selection in KRAS-mutated NSCLC
Adagrasib elicited higher efficacy in combination with mTOR inhibitors vs alone when treating patients with KRASG12C-mutant non–small cell lung cancer.
Conducting Early Phase Trials of Promising Treatments in Neuro-Oncology
Shwetal Mehta, PhD, emphasizes her institution’s patient-focused and scientifically rigorous philosophy when developing new therapies in brain cancer.
FDA Accepts BLA for Pertuzumab Biosimilar in HER2+ Breast Cancer
Data from analytical similarity studies and comparative clinical trials support the application of HLX11 in HER2-positive breast cancer.
Integrative Oncology Approaches to Managing Gastrointestinal Cancer
Options like acupuncture or cannabis use may be viable to help manage symptoms related to gastrointestinal cancer treatment.
